-
To encourage more people to participate in colorectal cancer screening, the American College of Physicians (ACP) issued new guidance on March 6. The statement is based on a critical review of existing guidelines developed by other US organisations including the American Cancer Society. ACP calls for colorectal cancer screening to start at the age of 50 years for people at average risk, and at 40 years (or 10 years before the age of the youngest case of colorectal cancer in a family) for people at high risk. Stool-based tests, flexible sigmoidoscopy, and optical colonoscopy are all acceptable screening options for people at average risk, say ACP, while the gold standard—optical colonoscopy—is recommended for people at high risk.
The Lancet - Tue, 20 March 2012
http://www.thelancet.com
-
In July, 2010, a 14-year-old boy was admitted to hospital with cyanosis and progressive dyspnoea: He had well established endocardial fibroelastosis...
The Lancet - Tue, 13 March 2012
http://www.thelancet.com
-
The Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension (TOPP) registry is a global, prospective study designed to provide information about demographics, treatment, and outcomes in paediatric pulmonary hypertension. It identifies important clinical features specific to the care of paediatric pulmonary hypertension, which draw attention to the need for paediatric data rather than extrapolation from adult studies.
The Lancet - Tue, 14 February 2012
http://www.thelancet.com
-
A long-awaited report by the Commission on Assisted Dying recommends an end to the criminalisation of assisted suicide in specific cases. David Holmes reports. The current legal status of assisted suicide in the UK is “inadequate and incoherent”, according to a wide-ranging report commissioned by the influential think tank Demos.
The Lancet - Tue, 10 January 2012
http://www.thelancet.com
-
Valsartan is more effective than amlodipine in reducing cardiac morbidity and mortality in hypertensive patients at high cardiovascular risk. these are the conclusions of the VALUE randomised, double blind clinical trial on more htan 15000 patients aged 50 years or older.
The Lancet - Mon, 7 November 2011
http://www.thelancet.com
-
The Lancet Series on Global Mental Health 2011 follows up on the pioneering set of papers published by the journal in 2007. It tracks progress over the past four years, and adds information to provide an indispensible resource for health workers and policymakers.
The Lancet - Tue, 25 October 2011
http://www.thelancet.com
-
The burden of cancer is growing rapidly, and the disease is becoming a major challenge for all developed countries. What are the drivers and solutions to the so-called cancer-cost curve in developed countries? The Lancet Oncology Commission on delivering affordable cancer care in high-income countries collects
expert opinion from health-care professionals, policy makers, and cancer survivors has been gathered to address the barriers and solutions to delivering affordable cancer-care in high-income countries.
The Lancet - Tue, 27 September 2011
http://www.thelancet.com
-
A small group of British—Libyan doctors set up a field hospital near the conflict zones in western Libya. One of them reports on his experiences and some of the casualties he saw.
The Lancet - Mon, 29 August 2011
http://www.thelancet.com
-
Twitter and social networking sites such as Facebook, together with podcasts, blogs, widgets, and RSS feeds now allow public health news and information and advice to spread rapidly, alongside comment, speculation, and misinformation.
The Lancet - Tue, 5 July 2011
http://www.thelancet.com
-
A randomised, double-blind, parallel-group trial showed similar rates of the primary endpoint with terutroban and aspirin, without safety advantages for terutroban. In a worldwide perspective, aspirin remains the gold standard antiplatelet drug for secondary stroke prevention in view of its efficacy, tolerance, and cost.
The Lancet - Tue, 14 June 2011
http://www.thelancet.com